News  
Scientific Publications  
 
 

Scientific Publications

Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
Felber LM, Kündig C, Borgoño CA, Chagas JR, Tasinato A, Jichlinski P, Gygi CM, Leisinger HJ, Diamandis EP, Deperthes D, Cloutier SM (2006) FEBS J (in press)

Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells
Fattah OM, Cloutier SM, Kündig C, Felber LM, Gygi CM, Jichlinski P, Leisinger HJ, Gauthier E, Mach JP, Deperthes D (2006) Int J Cancer (in press)

Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.
Felber LM, Borgoño CA, Cloutier SM, Kündig C, Kishi T, Chagas JR, Jichlinski P, Gygi CM, Leisinger HJ, Diamandis EP, Deperthes D (2005) Biol Chem, 386:291-8

Profiling of proteolytic activities secreted by cancer cells using phage display substrate technology
Cloutier SM, Kundig C, Gygi CM, Jichlinski P, Leisinger HJ, Deperthes D. (2004)
Tumour Biol, 25:24-30

Evaluation of the CFP-substrate-YFP system for protease studies: advantages and limitations
Felber LM, Cloutier SM, Kundig C, Kishi T, Brossard V, Jichlinski P, Leisinger HJ, Deperthes D. (2004) Biotechniques, 36:878-85

Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates
Cloutier SM, Kundig C, Felber LM, Fattah OM, Chagas JR, Gygi CM, Jichlinski P, Leisinger HJ, Deperthes D. (2004) Eur J Biochem, 271:607-13

Phage display substrate: a blind method for determining protease specificity
Deperthes D. (2002) Biol Chem, 383:1107-12

Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology
Cloutier SM, Chagas JR, Mach JP, Gygi CM, Leisinger HJ, Deperthes D. (2002) Eur J Biochem, 269:2747-54.